• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重叠性中毒性表皮坏死松解症和史蒂文斯-约翰逊综合征:病例报告及文献综述

Overlapping DRESS and Stevens-Johnson Syndrome: Case Report and Review of the Literature.

作者信息

Casagranda Aneline, Suppa Mariano, Dehavay Florence, Del Marmol Véronique

机构信息

Department of Dermatology and Venereology, Erasme Hospital, ULB, Brussels, Belgium.

出版信息

Case Rep Dermatol. 2017 May 8;9(2):1-7. doi: 10.1159/000475802. eCollection 2017 May-Aug.

DOI:10.1159/000475802
PMID:28611628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5465517/
Abstract

Drug-induced severe cutaneous adverse reactions (SCARs) include acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms (DRESS), and epidermal necrolysis (Stevens-Johnson syndrome [SJS], toxic epidermal necrolysis). The identification of the causal drug is crucial in order to avoid further exposure, but making the right differential diagnosis of the type of SCAR is equally important since treatment, follow-up, and prognosis of different SCARs are not the same. These syndromes are distinct entities with different clinical, biological, and histological patterns, but sometimes the early distinction between 2 SCARs can be extremely challenging, and overlapping conditions could therefore be taken into consideration, although true overlapping SCARs are very rare when using strict diagnostic criteria (described by the RegiSCAR group). Only a better understanding of the physiopathology of the SCARs could possibly explain these ambiguities and overlaps. We report a case of SCAR in an 86-year-old patient probably induced by allopurinol and simultaneously fulfilling the diagnostic criteria for DRESS and SJS, thus considered as an overlapping case of SCARs.

摘要

药物性严重皮肤不良反应(SCARs)包括急性泛发性脓疱性银屑病、伴有嗜酸性粒细胞增多和全身症状的药物反应(DRESS)以及表皮坏死松解症(史蒂文斯-约翰逊综合征[SJS]、中毒性表皮坏死松解症)。明确致病药物对于避免再次接触至关重要,但对SCAR类型做出正确的鉴别诊断同样重要,因为不同SCAR的治疗、随访及预后各不相同。这些综合征是具有不同临床、生物学和组织学表现的不同实体,但有时早期区分两种SCAR极具挑战性,因此可能需要考虑重叠情况,不过使用严格诊断标准(由RegiSCAR小组描述)时,真正重叠的SCAR非常罕见。只有更好地理解SCAR的生理病理学,才有可能解释这些模糊性和重叠情况。我们报告一例86岁患者的SCAR病例,可能由别嘌醇诱发,同时符合DRESS和SJS的诊断标准,因此被视为SCAR的重叠病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9029/5465517/6cb6f2525996/cde-0009-0001-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9029/5465517/846c6a3b3c0b/cde-0009-0001-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9029/5465517/296b34e3facc/cde-0009-0001-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9029/5465517/6cb6f2525996/cde-0009-0001-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9029/5465517/846c6a3b3c0b/cde-0009-0001-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9029/5465517/296b34e3facc/cde-0009-0001-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9029/5465517/6cb6f2525996/cde-0009-0001-g03.jpg

相似文献

1
Overlapping DRESS and Stevens-Johnson Syndrome: Case Report and Review of the Literature.重叠性中毒性表皮坏死松解症和史蒂文斯-约翰逊综合征:病例报告及文献综述
Case Rep Dermatol. 2017 May 8;9(2):1-7. doi: 10.1159/000475802. eCollection 2017 May-Aug.
2
Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist?中毒性表皮坏死松解症、DRESS、AGEP:是否存在重叠病例?
Orphanet J Rare Dis. 2012 Sep 25;7:72. doi: 10.1186/1750-1172-7-72.
3
Severe cutaneous adverse reactions: A 5-year retrospective study at Hospital Melaka, Malaysia, from December 2014 to February 2020.严重皮肤不良反应:马来西亚马六甲医院 2014 年 12 月至 2020 年 2 月的 5 年回顾性研究。
Med J Malaysia. 2022 Jul;77(4):409-414.
4
Systematic review of BRAF/MEK inhibitors-induced Severe Cutaneous Adverse Reactions (SCARs).BRAF/MEK抑制剂诱发的严重皮肤不良反应(SCARs)的系统评价。
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):607-614. doi: 10.1111/jdv.16894. Epub 2020 Sep 30.
5
Recognition and Management of Severe Cutaneous Adverse Drug Reactions (Including Drug Reaction with Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis).严重皮肤不良反应的识别和处理(包括药物反应伴嗜酸性粒细胞增多和全身症状、史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症)。
Med Clin North Am. 2021 Jul;105(4):577-597. doi: 10.1016/j.mcna.2021.04.001.
6
Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study.儿科患者的严重皮肤药物不良反应:一项多中心研究
J Allergy Clin Immunol Pract. 2017 May-Jun;5(3):757-763. doi: 10.1016/j.jaip.2017.02.013. Epub 2017 Mar 27.
7
A retrospective, 5-year, clinicoepidemiological study of severe cutaneous adverse reactions (SCARs).一项回顾性、5 年、临床流行病学研究严重皮肤不良反应 (SCARs)。
Int J Dermatol. 2021 May;60(5):579-588. doi: 10.1111/ijd.15416. Epub 2021 Jan 17.
8
Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9-year experience in a tertiary care paediatric hospital setting.儿童严重皮肤不良反应(SCARs)的病因发病机制:三级儿童保健医院 9 年经验。
Clin Exp Allergy. 2020 Jan;50(1):61-73. doi: 10.1111/cea.13513. Epub 2019 Oct 28.
9
Drug-induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan.药物性肝损伤与严重皮肤不良反应相关:台湾的一项全国性研究。
Liver Int. 2021 Nov;41(11):2671-2680. doi: 10.1111/liv.14990. Epub 2021 Jul 6.
10
A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions.一项多中心研究,旨在确定药物斑贴试验在三种主要严重皮肤不良反应类别的价值和安全性。
Br J Dermatol. 2013 Mar;168(3):555-62. doi: 10.1111/bjd.12125.

引用本文的文献

1
Overlapping of DRESS and Stevens-Johnson syndrome due to first-line antituberculosis drugs: a case report.一线抗结核药物所致中毒性表皮坏死松解症与史蒂文斯-约翰逊综合征重叠:1例报告
Ther Adv Drug Saf. 2025 Jan 24;16:20420986241312484. doi: 10.1177/20420986241312484. eCollection 2025.
2
A Rare Case of Fatal Toxic Epidermal Necrolysis (TEN) and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome in a Patient with Rheumatoid Arthritis.类风湿关节炎患者发生致命性中毒性表皮坏死松解症(TEN)及伴嗜酸性粒细胞增多和全身症状的药物反应(DRESS)综合征1例罕见病例
Curr Drug Saf. 2025;20(4):532-538. doi: 10.2174/0115748863337976241215162908.
3

本文引用的文献

1
Two cases of overlap severe cutaneous adverse reactions to benznidazole treatment for asymptomatic Chagas disease in a nonendemic country.两例在非流行地区因无症状恰加斯病而接受苯硝唑治疗的重叠严重皮肤不良反应病例。
Br J Dermatol. 2016 Sep;175(3):604-7. doi: 10.1111/bjd.14451. Epub 2016 Apr 7.
2
Piperacillin/Tazobactam-Associated Hypersensitivity Syndrome with Overlapping Features of Acute Generalized Exanthematous Pustulosis and Drug-Related Rash with Eosinophilia and Systemic Symptoms Syndrome.哌拉西林/他唑巴坦相关的超敏反应综合征,具有急性泛发性脓疱病和药物性皮疹伴嗜酸性粒细胞增多和全身症状综合征的重叠特征。
Ann Dermatol. 2016 Feb;28(1):98-101. doi: 10.5021/ad.2016.28.1.98. Epub 2016 Jan 28.
3
Stevens-Johnson syndrome with overlapping features of DRESS syndrome: A report of two cases.
伴有中毒性表皮坏死松解症重叠特征的史蒂文斯-约翰逊综合征:两例报告
SAGE Open Med Case Rep. 2024 Dec 19;12:2050313X241307097. doi: 10.1177/2050313X241307097. eCollection 2024.
4
DRESS syndrome: an interaction between drugs, latent viruses, and the immune system.药物性皮疹伴嗜酸性粒细胞增多和系统症状综合征:药物、潜伏病毒与免疫系统之间的相互作用。
An Bras Dermatol. 2025 Jan-Feb;100(1):104-120. doi: 10.1016/j.abd.2023.12.010. Epub 2024 Nov 8.
5
Toxic Epidermal Necrolysis Superimposed on Severe Drug Rash With Eosinophilia and Systemic Symptoms Complicated by Fatal Hemophagocytic Lymphohistiocytosis: A Case Report.中毒性表皮坏死松解症叠加严重药物性皮疹伴嗜酸性粒细胞增多和全身症状并合并致命性噬血细胞性淋巴组织细胞增生症:一例报告
Cureus. 2024 Sep 16;16(9):e69503. doi: 10.7759/cureus.69503. eCollection 2024 Sep.
6
DRESS and Stevens-Johnson Syndrome Overlap Secondary to Allopurinol in a 50-Year-Old Man-A Diagnostic and Treatment Challenge: Case Report.一名50岁男性因别嘌醇继发的中毒性表皮坏死松解症与史蒂文斯-约翰逊综合征重叠——诊断与治疗挑战:病例报告
Life (Basel). 2023 Nov 24;13(12):2251. doi: 10.3390/life13122251.
7
Overlapping Stevens-Johnson Syndrome and DRESS Syndrome Caused by Phenobarbital: A Vietnamese Case Report.苯巴比妥所致重叠型史蒂文斯-约翰逊综合征和药物反应伴嗜酸性粒细胞增多和系统症状综合征:1例越南病例报告
Glob Pediatr Health. 2023 Dec 5;10:2333794X231216556. doi: 10.1177/2333794X231216556. eCollection 2023.
8
Etanercept leads to a rapid recovery of a Dabrafenib-/Trametinib-associated toxic epidermal necrolysis-like severe skin reaction.依那西普可使与达拉非尼/曲美替尼相关的中毒性表皮坏死松解症样严重皮肤反应迅速恢复。
Skin Health Dis. 2022 Nov 5;3(1):e185. doi: 10.1002/ski2.185. eCollection 2023 Feb.
9
Human leukocyte antigen-associated severe cutaneous adverse drug reactions: from bedside to bench and beyond.人类白细胞抗原相关的严重皮肤药物不良反应:从床边到实验室再到更广泛领域
Asia Pac Allergy. 2019 May 31;9(3):e20. doi: 10.5415/apallergy.2019.9.e20. eCollection 2019 Jul.
Severe drug-induced skin reactions: clinical features, diagnosis, etiology, and therapy.
严重药物性皮肤反应:临床特征、诊断、病因及治疗
J Dtsch Dermatol Ges. 2015 Jul;13(7):625-45. doi: 10.1111/ddg.12747.
4
Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.HLA-B*1502 等位基因与卡马西平诱导的 Stevens-Johnson 综合征和中毒性表皮坏死松解症的关系:系统评价和荟萃分析。
JAMA Dermatol. 2013 Sep;149(9):1025-32. doi: 10.1001/jamadermatol.2013.4114.
5
Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment.中毒性表皮坏死松解症:第二部分。预后、后遗症、诊断、鉴别诊断、预防和治疗。
J Am Acad Dermatol. 2013 Aug;69(2):187.e1-16; quiz 203-4. doi: 10.1016/j.jaad.2013.05.002.
6
Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis.中毒性表皮坏死松解症:第一部分。引言、历史、分类、临床特征、全身表现、病因和免疫发病机制。
J Am Acad Dermatol. 2013 Aug;69(2):173.e1-13; quiz 185-6. doi: 10.1016/j.jaad.2013.05.003.
7
DRESS syndrome: Part I. Clinical perspectives.药物反应伴嗜酸性粒细胞增多和全身性症状(DRESS)综合征:第一部分. 临床观点。
J Am Acad Dermatol. 2013 May;68(5):693.e1-14; quiz 706-8. doi: 10.1016/j.jaad.2013.01.033.
8
Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist?中毒性表皮坏死松解症、DRESS、AGEP:是否存在重叠病例?
Orphanet J Rare Dis. 2012 Sep 25;7:72. doi: 10.1186/1750-1172-7-72.
9
[Management of drug reaction with eosinophilia and systemic symptoms (DRESS)].嗜酸性粒细胞增多和全身症状的药物反应(DRESS)的管理
Ann Dermatol Venereol. 2010 Nov;137(11):703-8. doi: 10.1016/j.annder.2010.04.024. Epub 2010 Aug 5.
10
Nonimmediate allergic reactions induced by drugs: pathogenesis and diagnostic tests.药物引起的非即刻过敏反应:发病机制与诊断测试
J Investig Allergol Clin Immunol. 2009;19(2):80-90.